ESC 365 - Aliskiren alone and in combination with enalapril, versus enalapril, in heart failure patients with diabetes.

HFA Premium Access

Aliskiren alone and in combination with enalapril, versus enalapril, in heart failure patients with diabetes.

Session: Late Breaking Trials III: Focus on trial updates, registries and meta-analyses

Topic: Miscellaneous

Speaker: Professor L. Kober (Copenhagen, DK)

Event: HEART FAILURE 2016

Congress Presentation

Add to my library

About the speaker

Professor Lars Kober

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

26 presentations

4 followers

11 more presentations in this session

Influenza vaccination and risk of hospitalisation in patients with heart failure: a report from the UK primary and secondary care records.

Speaker: Professor K. Rahimi (Oxford, GB)

Discussion: Influenza vaccination and risk of hospitalisation in patients with heart failure: a report from the UK primary and secondary care records.

Discussion: Aliskiren alone and in combination with enalapril, versus enalapril, in heart failure patients with diabetes.

Effect of cardiac resynchronization in patients with diabetes enrolled in echoCRT.

Speaker: Doctor M. Naegele (Zurich, CH)

Discussion: Effect of cardiac resynchronization in patients with diabetes enrolled in echoCRT.

Access the full session

Late Breaking Trials III: Focus on trial updates, registries and meta-analyses

Speakers: Professor L. Kober, Professor K. Rahimi, Doctor M. Naegele

About the event

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources